Shiraz E-Medical Journal

Published by: Kowsar

Medication Adherence and its Predictors in Type 2 Diabetic Patients Referring to Urban Primary Health Care Centers in Kerman City, Southeastern Iran

Lila Benrazavy 1 and Ali Khalooei ORCID 1 , *
Authors Information
1 Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
Article information
  • Shiraz E-Medical Journal: 20 (7); e84746
  • Published Online: May 19, 2019
  • Article Type: Research Article
  • Received: September 29, 2018
  • Revised: December 30, 2018
  • Accepted: January 11, 2019
  • DOI: 10.5812/semj.84746

To Cite: Benrazavy L, Khalooei A. Medication Adherence and its Predictors in Type 2 Diabetic Patients Referring to Urban Primary Health Care Centers in Kerman City, Southeastern Iran, Shiraz E-Med J. Online ahead of Print ; 20(7):e84746. doi: 10.5812/semj.84746.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. World Health Organization. Global report on diabetes. 2016. Available from:
  • 2. Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98. doi: 10.1038/nrendo.2017.151. [PubMed: 29219149].
  • 3. Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes care in Iran: Where we stand and where we are headed. Ann Glob Health. 2015;81(6):839-50. doi: 10.1016/j.aogh.2015.10.003. [PubMed: 27108151].
  • 4. Inamdar SZ, Kulkarni RV, Karajgi SR, Manvi FV, Ganachari MS, Kumar BM. Medication adherence in diabetes mellitus: An overview on pharmacist role. Open J Adv Drug Delivery. 2013;1(3):238-50.
  • 5. Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Front Endocrinol (Lausanne). 2017;8:6. doi: 10.3389/fendo.2017.00006. [PubMed: 28167928]. [PubMed Central: PMC5256065].
  • 6. Nash J. Understanding barriers to medication adherence in people with diabetes. J Diabetes Nurs. 2013;17(7):263-7.
  • 7. Lam WY, Fresco P. Medication adherence measures: An overview. Biomed Res Int. 2015;2015:217047. doi: 10.1155/2015/217047. [PubMed: 26539470]. [PubMed Central: PMC4619779].
  • 8. Elsous A, Radwan M, Al-Sharif H, Abu Mustafa A. Medications adherence and associated factors among patients with type 2 diabetes mellitus in the gaza strip, Palestine. Front Endocrinol (Lausanne). 2017;8:100. doi: 10.3389/fendo.2017.00100. [PubMed: 28649231]. [PubMed Central: PMC5465265].
  • 9. Park KA, Kim JG, Kim BW, Kam S, Kim KY, Ha SW, et al. Factors that affect medication adherence in elderly patients with diabetes mellitus. Korean Diabetes J. 2010;34(1):55-65. doi: 10.4093/kdj.2010.34.1.55. [PubMed: 20532021]. [PubMed Central: PMC2879904].
  • 10. Sharma T, Kalra J, Dhasmana DC, Basera H. Poor adherence to treatment: A major challenge in diabetes. J Indian Acad Clin Med. 2014;15(1):26-9.
  • 11. Rwegerera GM, Moshomo T, Gaenamong M, Oyewo TA, Gollakota S, Mhimbira FA, et al. Antidiabetic medication adherence and associated factors among patients in Botswana; implications for the future. Alexandria J Med. 2018;54(2):103-9. doi: 10.1016/j.ajme.2017.01.005.
  • 12. Lee CS, Tan JHM, Sankari U, Koh YLE, Tan NC. Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: A cross-sectional study. BMJ Open. 2017;7(9). e016317. doi: 10.1136/bmjopen-2017-016317. [PubMed: 28912194]. [PubMed Central: PMC5640112].
  • 13. Mashrouteh M, Khanjani N. Evaluation of oral medication adherence and its related factors in type II diabetic patients in Iran: A systematic review. Int J Diabet Res. 2017;6(1):24-33. doi: 10.5923/j.diabetes.20170601.04.
  • 14. Plos One Staff . Correction: Validity and reliability of a self-reported measure of antihypertensive medication adherence in Uganda. PLoS One. 2017;12(10). e0187620. doi: 10.1371/journal.pone.0187620. [PubMed: 29088305]. [PubMed Central: PMC5663509].
  • 15. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54. [PubMed: 18453793]. [PubMed Central: PMC2562622].
  • 16. Moharamzad Y, Saadat H, Nakhjavan Shahraki B, Rai A, Saadat Z, Aerab-Sheibani H, et al. Validation of the Persian version of the 8-item morisky medication adherence scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci. 2015;7(4):173-83. doi: 10.5539/gjhs.v7n4p173. [PubMed: 25946926]. [PubMed Central: PMC4802120].
  • 17. Dehghan M, Nayeri N, Karimzadeh P, Iranmanesh S. Psychometric properties of the persian version of the morisky medication adherence scale-8. Brit J Med Res. 2015;9(9):1-10. doi: 10.9734/bjmmr/2015/17345.
  • 18. Jimmy B, Jose J. Patient medication adherence: Measures in daily practice. Oman Med J. 2011;26(3):155-9. doi: 10.5001/omj.2011.38. [PubMed: 22043406]. [PubMed Central: PMC3191684].
  • 19. Lin LK, Sun Y, Heng BH, Chew DEK, Chong PN. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res Care. 2017;5(1). e000429. doi: 10.1136/bmjdrc-2017-000429. [PubMed: 28878942]. [PubMed Central: PMC5574459].
  • 20. Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, et al. Determinants of adherence to diabetes medications: Findings from a large pharmacy claims database. Diabetes Care. 2015;38(4):604-9. doi: 10.2337/dc14-2098. [PubMed: 25573883]. [PubMed Central: PMC4370331].
  • 21. Serap T, Bayram Ş. Factors influencing adherence to diabetes medication in Turkey. Sch J Appl Med Sci. 2015;3(2A):602-7.
  • 22. Goh BQ, Tay AHP, Khoo RSY, Goh BK, Lo PFL, Lim CJF. Effectiveness of medication review in improving medication knowledge and adherence in primary care patients. Proc Singapore Healthcare. 2014;23(2):134-41. doi: 10.1177/201010581402300207.
  • 23. Bazargan M, Smith J, Yazdanshenas H, Movassaghi M, Martins D, Orum G. Non-adherence to medication regimens among older African-American adults. BMC Geriatr. 2017;17(1):163. doi: 10.1186/s12877-017-0558-5. [PubMed: 28743244]. [PubMed Central: PMC5526276].
  • 24. Katz LL, Anderson BJ, McKay SV, Izquierdo R, Casey TL, Higgins LA, et al. Correlates of medication adherence in the TODAY cohort of youth with type 2 diabetes. Diabetes Care. 2016;39(11):1956-62. doi: 10.2337/dc15-2296. [PubMed: 27352955]. [PubMed Central: PMC5079608].
  • 25. El-Khawaga G, Abdel-Wahab F. Knowledge, attitudes, practice and compliance of diabetic patients in Dakahlia, Egypt. Europ J Res Med Sci. 2015;3(1).
  • 26. Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299-307. doi: 10.2147/PPA.S106821. [PubMed: 27524885]. [PubMed Central: PMC4966497].
  • 27. Ahmad NS, Ramli A, Islahudin F, Paraidathathu T. Medication adherence in patients with type 2 diabetes mellitus treated at primary health clinics in Malaysia. Patient Prefer Adherence. 2013;7:525-30. doi: 10.2147/PPA.S44698. [PubMed: 23814461]. [PubMed Central: PMC3693921].
  • 28. Tiv M, Viel JF, Mauny F, Eschwege E, Weill A, Fournier C, et al. Medication adherence in type 2 diabetes: The ENTRED study 2007, a French population-based study. PLoS One. 2012;7(3). e32412. doi: 10.1371/journal.pone.0032412. [PubMed: 22403654]. [PubMed Central: PMC3293796].
  • 29. Farsaei S, Sabzghabaee AM, Amini M, Zargarzadeh AH. Adherence to statin therapy in patients with type 2 diabetes: An important dilemma. J Res Med Sci. 2015;20(2):109-14. [PubMed: 25983760]. [PubMed Central: PMC4400702].
  • 30. Jimmy B, Jose J, Al-Hinai ZA, Wadair IK, Al-Amri GH. Adherence to medications among type 2 diabetes mellitus patients in three districts of Al Dakhliyah Governorate, Oman: A cross-sectional pilot study. Sultan Qaboos Univ Med J. 2014;14(2):e231-5. [PubMed: 24790747]. [PubMed Central: PMC3997541].
  • 31. Sweileh WM, Zyoud SH, Abu Nab'a RJ, Deleq MI, Enaia MI, Nassar SM, et al. Influence of patients' disease knowledge and beliefs about medicines on medication adherence: Findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health. 2014;14:94. doi: 10.1186/1471-2458-14-94. [PubMed: 24479638]. [PubMed Central: PMC3909379].
  • 32. Sarbacker GB, Urteaga EM. Adherence to insulin therapy. Diabetes Spectr. 2016;29(3):166-70. doi: 10.2337/diaspect.29.3.166. [PubMed: 27574371]. [PubMed Central: PMC5001221].
  • 33. Donnelly LA, Morris AD, Evans JM, Darts Memo collaboration . Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM. 2007;100(6):345-50. doi: 10.1093/qjmed/hcm031. [PubMed: 17504861].
  • 34. Mukherjee S. Compliance to anti-diabetic drugs: Observations from the diabetic clinic of a medical college in Kolkata, India. J Clin Diagn Res. 2013. doi: 10.7860/jcdr/2013/5352.2876.
  • 35. Polonsky WH. Poor medication adherence in diabetes: What's the problem? J Diabetes. 2015;7(6):777-8. doi: 10.1111/1753-0407.12306. [PubMed: 25929829].
  • 36. Ivanov NN. Patient-physician communication and diabetes self-care. J Clin Outcomes Manag. 2016;23(11):509-18.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments